Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The continuous glucose monitoring (CGM) market has seen remarkable growth recently, driven by advancements in technology and an increasing global focus on diabetes management. As more people seek effective and convenient ways to monitor their blood sugar levels, this market is set to expand significantly over the coming years. Let’s explore the market’s current size, growth drivers, major players, evolving trends, and segmentation to understand the landscape in greater detail.
Continuous Glucose Monitoring Market Size and Growth Projections
The continuous glucose monitoring market has been growing rapidly and is expected to continue this trend. From a market size of $9.44 billion in 2025, it is projected to reach $10.87 billion in 2026, representing a healthy compound annual growth rate (CAGR) of 15.1%. This expansion during the historical period stems from factors like limited availability of real-time glucose monitoring devices, the high price of earlier CGM systems, increasing awareness of diabetes care, reliance on traditional finger-prick testing, and wider adoption of monitoring solutions in hospitals. Looking further ahead, the market is forecasted to reach $18.86 billion by 2030, growing at a CAGR of 14.8%. The anticipated growth is driven by innovations in implantable and wearable sensors, integration with mobile health and telemedicine technologies, a rising global diabetes population, development of non-invasive glucose monitoring methods, and the growing use of home healthcare and remote patient monitoring services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24512&type=smp
Key Factors Fueling the Growth of the CGM Market
One of the most significant forces behind the rapid growth of the continuous glucose monitoring market is the increasing prevalence of diabetes worldwide. Diabetes, a chronic condition characterized by insufficient insulin production or ineffective insulin use, results in elevated blood sugar levels. The surge in diabetes cases is largely linked to unhealthy diets rich in sugars, fats, and processed foods, which contribute to obesity and insulin resistance. Continuous glucose monitoring offers a valuable tool in managing diabetes by providing real-time insights into blood sugar trends, allowing patients to make timely decisions regarding diet, medication, and physical activity to improve glucose control.
For example, in June 2024, the UK’s National Health Service reported that 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. This rise in pre-diabetes highlights the growing need for effective glucose monitoring technologies, which is a key market driver.
Continuous Glucose Monitoring Market Segmentation and Growth Opportunities
The CGM market is categorized by several segments, which help to define the scope and potential of this industry. The main divisions include:
1) Component Type: Transmitters, Sensors, and Receivers
2) Age Group: Adults and Children
3) End Use: Hospitals, Home Care Settings, Diagnostic Centers and Clinics, and Other End Uses
Further breakdown includes transmitter types such as reusable, disposable, and rechargeable transmitters; various sensor types like implantable, transcutaneous, disposable, and real-time sensors; and receiver types including standalone devices, integrated receivers, and wearable display units. These segments pave the way for targeted product development and service delivery catering to different patient needs and healthcare environments.
Access The Complete Continuous Glucose Monitoring Market Report:
https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-global-market-report
Trends Driving Innovation in the Continuous Glucose Monitoring Market
Leading companies in the CGM sector are heavily investing in innovative technologies aimed at improving accuracy, ease of use, and patient experience. Sensor-based glucose monitors, which continuously track glucose levels through sensors placed under the skin, are a major focus area for product development.
For instance, in August 2024, DexCom, Inc., a US-based healthcare firm, launched Stelo, the first over-the-counter continuous glucose monitor designed for adults who do not use insulin. Stelo provides 24/7 real-time glucose readings from a small sensor worn on the back of the upper arm, transmitting data directly to a smartphone without requiring prescriptions or fingerstick calibration. It offers personalized insights and trend analysis to help users understand how factors like diet, exercise, and sleep impact glucose levels, supporting smarter decisions. The sensor has a lifespan of up to 15 days and integrates with health applications. This product is ideal for individuals with Type 2 diabetes not on insulin, those with prediabetes, or people interested in monitoring their glucose health.
Who Are the Key Players Shaping the Continuous Glucose Monitoring Market
The CGM market features several prominent companies that dominate the competitive landscape. These include Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, and POCTech Co Ltd. These companies are continuously advancing CGM technology and expanding their product portfolios to meet diverse patient needs worldwide.
Regional Overview and Market Growth by Geography
In 2025, North America held the largest share of the continuous glucose monitoring market, reflecting the region’s well-established healthcare infrastructure and high adoption rates of advanced medical devices. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth over the forecast period. This surge is driven by increasing diabetes prevalence, improving healthcare systems, rising disposable incomes, and expanding access to medical technology in countries across Asia-Pacific. The continuous glucose monitoring market report also covers other key regions such as South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
